Clinical Trial Update: HBV Reactivation in Immunocompromised Patients (REANT STUDY)

View source ↗

Summary

A clinical trial called REANT STUDY is currently recruiting to investigate hepatitis B virus reactivation in immunocompromised patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Yaşar Bayındır, MD | Conditions: HBV | Status: RECRUITING